IFP Advisors Inc Takes $36,000 Position in Kewaunee Scientific Co. (NASDAQ:KEQU)

IFP Advisors Inc purchased a new stake in Kewaunee Scientific Co. (NASDAQ:KEQU) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 585 shares of the technology company’s stock, valued at approximately $36,000.

Several other hedge funds and other institutional investors also recently modified their holdings of KEQU. De Lisle Partners LLP increased its stake in shares of Kewaunee Scientific by 36.6% in the 3rd quarter. De Lisle Partners LLP now owns 42,958 shares of the technology company’s stock valued at $1,446,000 after purchasing an additional 11,511 shares during the last quarter. State Street Corp bought a new position in shares of Kewaunee Scientific in the 3rd quarter valued at $266,000. Janney Montgomery Scott LLC bought a new position in shares of Kewaunee Scientific in the 4th quarter valued at $338,000. Barclays PLC bought a new position in shares of Kewaunee Scientific in the 3rd quarter valued at $121,000. Finally, Geode Capital Management LLC increased its stake in shares of Kewaunee Scientific by 8.9% in the 3rd quarter. Geode Capital Management LLC now owns 23,784 shares of the technology company’s stock valued at $792,000 after purchasing an additional 1,941 shares during the last quarter. Institutional investors own 32.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Kewaunee Scientific from a “hold” rating to a “buy” rating in a research note on Wednesday, December 18th.

Insider Buying and Selling

In other Kewaunee Scientific news, CFO Donald T. Gardner III sold 1,257 shares of Kewaunee Scientific stock in a transaction dated Friday, January 10th. The stock was sold at an average price of $59.26, for a total transaction of $74,489.82. Following the transaction, the chief financial officer now directly owns 21,358 shares of the company’s stock, valued at approximately $1,265,675.08. The trade was a 5.56 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Elizabeth D. Phillips sold 1,850 shares of Kewaunee Scientific stock in a transaction dated Tuesday, December 17th. The stock was sold at an average price of $54.17, for a total value of $100,214.50. Following the transaction, the vice president now directly owns 13,591 shares in the company, valued at $736,224.47. The trade was a 11.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 11,994 shares of company stock worth $729,430 in the last 90 days. Insiders own 14.20% of the company’s stock.

Kewaunee Scientific Trading Down 3.6 %

Shares of KEQU stock opened at $49.38 on Friday. The firm has a market capitalization of $141.82 million, a P/E ratio of 7.83 and a beta of 0.71. Kewaunee Scientific Co. has a twelve month low of $27.00 and a twelve month high of $71.33. The company has a quick ratio of 2.13, a current ratio of 2.64 and a debt-to-equity ratio of 0.45. The stock’s fifty day simple moving average is $60.39 and its 200 day simple moving average is $48.08.

Kewaunee Scientific (NASDAQ:KEQU) last issued its quarterly earnings data on Wednesday, December 11th. The technology company reported $1.41 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.83% and a net margin of 9.39%.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.